Max Drawdown (5Y) Chart

Historical Max Drawdown (5Y) Data

View and export this data back to 1995. Start Trial.
Date Value
September 30, 2026 34.60%
August 31, 2026 34.60%
July 31, 2026 34.60%
June 30, 2026 34.60%
May 31, 2026 34.60%
April 30, 2026 34.60%
March 31, 2026 34.60%
February 28, 2026 34.60%
January 31, 2026 34.60%
December 31, 2025 34.60%
November 30, 2025 34.60%
October 31, 2025 34.60%
September 30, 2025 34.60%
August 31, 2025 34.60%
July 31, 2025 34.60%
June 30, 2025 34.60%
May 31, 2025 34.60%
April 30, 2025 34.60%
March 31, 2025 41.98%
February 28, 2025 46.58%
January 31, 2025 46.58%
December 31, 2024 46.58%
November 30, 2024 46.58%
October 31, 2024 46.58%
September 30, 2024 46.58%
Date Value
August 31, 2024 46.58%
July 31, 2024 46.58%
June 30, 2024 46.58%
May 31, 2024 46.58%
April 30, 2024 46.58%
March 31, 2024 46.58%
February 29, 2024 46.58%
January 31, 2024 46.58%
December 31, 2023 46.58%
November 30, 2023 46.58%
October 31, 2023 46.58%
September 30, 2023 46.58%
August 31, 2023 46.58%
July 31, 2023 46.58%
June 30, 2023 46.58%
May 31, 2023 46.58%
April 30, 2023 46.58%
March 31, 2023 46.58%
February 28, 2023 46.58%
January 31, 2023 46.58%
December 31, 2022 46.58%
November 30, 2022 46.58%
October 31, 2022 46.58%
September 30, 2022 46.58%
August 31, 2022 46.58%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Quest Diagnostics, Inc. 28.60%
DaVita, Inc. 51.10%
CVS Health Corp. 56.78%
OPKO Health, Inc. 85.55%
Psychemedics Corp. 87.72%